Oncotarget is a medical journal with open access that is weekly peer-reviewed. The journal covers research on all issues concerning oncology. Oncotarget was started in 2010. The Impact Journals are its publishers. Mikhail Blagosklonny and Andrei Gudkov are both from the Roswell Park Cancer Institute. They serve as Oncotarget’s editors-in-chief. Oncotarget is a multidisciplinary journal. It publishes its papers online every week. Every article or issue can be printed in case a reader has a special demand. Oncotarget has been serving its readers with scientific research results for more than seven years. It has acquired a reputation as an efficient and reliable oncology journal.
The mission of Oncotarget is to avail scientific results to their international readers rapidly. The Journal also uses insightful review so as to maximize the research impact. Oncotarget enables quick sharing of exceptional discoveries. The journal has helped to remove the border that has been in existence between specialties. Oncotarget aims to connect various biomedical science fields and to promote the applications of both clinical and basic science in battling the disease. Oncotarget is headed by some of the most prominent scientists in the world. The journal has assisted many researchers in contributing to the progress and growth of science. The ultimate goal of Oncotarget is to ensure that people live a life with no diseases. Learn more about Oncotarget at Bioxbio.com.
The Journal has managed to launch other sections apart from oncology because of the success that it has experienced over the years. These include cardiology, neuroscience, cell biology, endocrinology, all areas of pharmacology, metabolism, and many more topics. The journal encourages young scientists to send their papers and articles on scientific research. Oncotarget has risen in popularity among readers because of the constructive, insightful, and punctual release of scientific results. Four Oncotarget members won the breakthrough prize in 2013. These members include Alexander Varshavsky, Michael Hall, Stephen Elledge, and Bert Vogelstein.
Oncotarget is the sponsors of the Gordon Research Conference. The journal has an impact factor of 5.008. This is according to reports by the Journal Citation in 2012. The word Oncotarget encompasses all cellular functions, molecules, and pathways found in aging and cancer. Check Oncotarget journal at scimagojr.com